Follow The Filings

JKHY Jack Henry & Associates

Jack Henry & Associates earnings company data as of 6:58 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 2.05 — —
Rev — — —
FY2026 Q4 18 Aug EPS 1.44 — —
Rev — — —

Insider trades

Open-market buys and sales by JKHY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JKHY insider trades
  • $317K bought by 2 insiders
  • $3.5M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Gregory R. Adelson CEO
    Buy
    $267K 2,000 shares at $133.42 +11% to stake
    Traded May 14 Filed May 14
    ↗
  2. Mimi Carsley CFO
    Buy
    $50K 375 shares at $134.12 +6.7% to stake
    Traded May 14 Filed May 14
    ↗
  3. David B Foss Director
    Sale
    $3.5M 20,000 shares at $174.92 14% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  4. Shanon G. McLachlan COO
    Sale
    $37K 227 shares at $160.83 14% of stake
    Traded Nov 10, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 share withholdings for taxes, 22 option exercises, 12 stock grants, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
DEF 14A JKHY - DEF 14A - JKHY PROXY STATEMENT FY2026 Filing Doc
DEFA14A DEFA14A - PROXY NOTICE FY2026 Filing Doc
10-K 10-K - JKHY - 2026.06.30 FY2026 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q 10-Q - JKHY - 2026.03.31 - Q3 FY2026 Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q 10-Q - JKHY - 2025.12.31 - Q2 FY2026 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.